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Abstract
One of the challenges in studying early differentiation of human embryonic stem cells (hESCs) is being able to discriminate
the initial differentiated cells from the original pluripotent stem cells and their committed progenies. It remains unclear how
a pluripotent stem cell becomes a lineage-specific cell type during early development, and how, or if, pluripotent genes,
such as Oct4 and Sox2, play a role in this transition. Here, by studying the dynamic changes in the expression of embryonic
surface antigens, we identified the sequential loss of Tra-1-81 and SSEA4 during hESC neural differentiation and isolated
a transient Tra-1-81(2)/SSEA4(+) (TR2/S4+) cell population in the early stage of neural differentiation. These cells are
distinct from both undifferentiated hESCs and their committed neural progenitor cells (NPCs) in their gene expression
profiles and response to extracellular signalling; they co-express both the pluripotent gene Oct4 and the neural marker
Pax6. Furthermore, these TR2/S4+ cells are able to produce cells of both neural and non-neural lineages, depending on
their environmental cues. Our results demonstrate that expression of the pluripotent factor Oct4 is progressively
downregulated and is accompanied by the gradual upregulation of neural genes, whereas the pluripotent factor Sox2 is
consistently expressed at high levels, indicating that these pluripotent factors may play different roles in the regulation of
neural differentiation. The identification of TR-S4+ cells provides a cell model for further elucidation of the molecular
mechanisms underlying hESC neural differentiation.
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Introduction
The developmental processes of many organs and tissues in an
embryo originate from the pluripotent cells of the inner cell mass
(ICM) in the blastocyst. As development proceeds, these cells
gradually acquire specialized traits, becoming committed to
specific fates and losing their potential to differentiate into other
cell types. For example, the development of the central nervous
system is initiated following gastrulation by the induction of the
neuroectoderm, a process by which embryonic cells acquire
a neural fate to form a single layer of neuroepithelial cells [1].
These cells subsequently give rise to neural stem and progenitor
cells, which undergo further differentiation to neurons and glia [2].
This multi-step cell fate determination that occurs during
embryonic neurogenesis is delicately orchestrated by many
signalling pathways and transcription factors. Although consider-
able efforts have been focused on ascertaining the emergence of
these earliest potential neural cells and the regulatory mechanisms
that govern the process of neural induction, they have yet to be
fully defined. This is largely due to the lack of adequate tissues
from the early developmental stages.
Human embryonic stem cells (hESCs) derived from the ICM of
blastocysts are capable of self-renewal in culture indefinitely and
meanwhile retain the developmental pluripotency of the embry-
onic founder cells, having the potential to differentiate into all the
cells and tissues in a human body [3]. Therefore, they provide not
only a potential source of specialized cells for regenerative
therapies but also a valuable in vitro model to study early human
development, particularly as the direct study of early human
embryo development is severely hampered by the inability to
obtain adequate amounts of tissues at all developmental stages.
Although differentiation of ESCs may not fully recapitulate the
development of the embryo, increasing evidence demonstrates that
their lineage-specific differentiation nonetheless reflects the de-
velopmental progression of that cell type in vivo [4–7]. Therefore,
the use of hESCs to investigate early human embryo development
may provide valuable insights into early developmental processes,
including neural induction.
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37129The Oct4 transcription factor plays an essential role in the
maintenance of pluripotency and self-renewal of ESCs [8,9] and is
also a critical reprogramming factor [10]. In mouse, Oct4 is
initially expressed in all the blastomeres of the morula, with its
expression becoming successively restricted to the ICM of the
blastocyst. After gastrulation, the expression of Oct4 is concen-
trated in the primitive ectoderm and persists through E7.5 in
unsegmented areas, but is downregulated as development con-
tinues. By E9.5, its expression is limited to primordial germ cells
[11]. In human, Oct4 expression remained at stage 9 post-
implantation embryos [12]. In the absence of Oct4, embryos are
unable to form pluripotent ICM and fail to produce any other
lineages, except for extraembryonic trophoblasts [13]. Corre-
spondingly, forced downregulation of Oct4 in mouse and human
ESCs results in their differentiation into extraembryonic lineages
[8,14,15]. Taken together, this implies that Oct4 plays a significant
role in embryogenesis and early lineage differentiation.
We have previously shown that hESCs can be efficiently
differentiated to neural progenitors by the inhibition of BMP [16].
During the initial differentiation, expression of Oct4 remains
detectableforatleastoneweekuntiltheformationofneuroepithelial
cells after week 2. Little is known about these early differentiating
cells and it is not clear whether this initial Oct4 expressing
population differ from undifferentiated hESCs. In this study, we
carefully identified and isolated this initial differentiating cell
population and demonstrated that these cells are distinct from
undifferentiated hESCs and committed neural progenitor cells
(NPCs), exhibiting intermediate features between the two. The
identification of these early neural differentiating cells will provide
a valuable cell source which can be used to elucidate the molecular
mechanisms that regulate neuroectoderm development.
Results
Identification of a transient Tra-1-81(2)/SSEA4(+) cell
population at early stage neural differentiation of hESCs
Similar to the cells in the ICM, undifferentiated hESCs express
embryonic cell specific surface antigens, including stage-specific
embryonic antigens (SSEA) 3 and 4, Tra-1-60 and Tra-1-81 [17],
which were first identified in human embryonic carcinomas.
However, unlike mESCs, they do not express SSEA1. Although
the functional significance of these antigens is as yet unclear, they
are routinely used as markers for hESCs. Therefore, we
anticipated that studying the dynamic changes of these cell surface
markers in neural differentiation could potentially enable us to
capture and isolate the early differentiating populations which
could be used for further analysis.
We focused our study on Tra-1-81, SSEA4 and SSEA1, given
that SSEA3 expression is not necessarily required for a pluripotent
state [18], and the high similarity between Tra-1-60 and Tra-1-81
[19]. Our results showed that, in self-renewal culture conditions,
H1 hESCs express high levels of SSEA4 and TRA-1-81, but not
SSEA1 (Figure 1A, top). After differentiation to neural progeni-
tors, expression of Tra-1-81 and SSEA4 were lost while expression
of SSEA1 was increased (Figures 1A, bottom). However, it is
noteworthy that the loss of Tra-1-81 preceded that of SSEA4.
After 9 days in neural differentiation medium, Tra-1-81 expression
was almost completely lost, whereas the majority of cells still
expressed SSEA4 (Figure 1A, middle). The expression of SSEA4
persisted for several days until 2 weeks into the differentiation at
which point the neuroepithelial cells started to emerge and SSEA1
expression was positive. A similar pattern was also observed in H7
hESCs, although Tra-1-81 expression was lost earlier than that in
the H1 cells (7 days vs. 9 days) (Figure 1B). The existence of this
Tra-1-81(2)/SSEA4(+) population of cells was also confirmed by
immunostaining (Figure 1C). Further neural differentiation from
this stage lead to the efficient generation of NPCs, which retained
the expression pattern of Tra-1-81(2)/SSEA4(2)/SSEA1(+) and
could be maintained for an extended time in culture when
supplemented with bFGF/EGF (Figure 1D). The neural differen-
tiation experiments were repeated several times in both H1 and
H7 hESC lines and the sequential loss of the Tra-1-81 and SSEA4
antigens was reproducible, although the timing of the disappear-
ance of each antigen varied slightly between experiments,
depending on the initial seeding density.
To eliminate the possibility that the sequential loss of Tra-1-81
and SSEA4 is a culture-dependent phenomenon, hESCs were also
differentiated using the double SMADs inhibition protocol
[20,21]. Differentiation with the dual SMAD inhibitors exhibited
the same sequential loss of Tra-1-81 and SSEA4 in both H1 and
H7 cells (Figure S1A). Furthermore, a previous report using
stromal-feeder based neural differentiation protocol observed the
same effect [19]. We therefore propose that this initial Tra-1-81(2)
and SSEA4(+) population represent cells of early neural differen-
tiation and consequently designated them TR2/S4+ cells.
TR2/S4+ cells exhibit an intermediate gene expression
pattern between hESCs and neural progenitors
Different cell populations can be distinguished by morpholog-
ical and developmental criteria, as well as by the temporal and
spatial expression of marker genes. In order to characterize the
transient TR2/S4+ cells, we isolated them by FACS or by
magnetic-activated cell purification (Figure 2A). The Tra-1-81(2)
and SSEA4(+) identity of the purified cells was then confirmed by
flow cytometry analysis. Gene expression was analysed by
quantitative RT-PCR (qRT-PCR) and compared to that of
undifferentiated TR+/S4+ hESCs and their TR2/S42 NPCs
(Figure 2B). We found that the expression of pluripotent marker
genes, Oct4, Nanog and Rex1, was clearly downregulated in the
TR2/S4+ cells compared to hESCs but remained higher than
that of NPCs. Conversely, the expression of neural progenitor
marker genes, Pax6, nestin and Sox1, was upregulated in the TR2/
S4+ cells but was considerably lower than in NPCs. However,
Sox2, another known pluripotent marker, was consistently
expressed in all three cell types, with its highest expression level
in the NPCs, implicating a critical role in both pluripotent and
neural progenitor cells. In addition, the TR2/S4+ cells also
expressed the early differentiation marker, FGF5, which was
undetected in both hESCs and NPCs (Figure 2B). A similar gene
expression pattern was also found in TR2/S4+ cells from neural
differentiation with dual SMAD inhibitors. It was also found by
RT-PCR that, compared to the undifferentiated hESCs and their
NPCS derivatives, both the isolated TR2/S4+ cells and the
unsorted day 9 differentiated H1 cells expressed much lower levels
of leukaemia inhibitory factor receptor (LIFR) (Figure 2C).
Western blotting was performed to confirm the expression of
Oct4 and Nanog proteins (Figure 3A). While undifferentiated
hESCs exhibited high levels of Oct4 and Nanog proteins, they were
undetectable in NPCs. However, in the TR2/S4+ cells, Oct4 and
Nanog protein levels were lower than in hESCs but higher than in
the NPCs. Since both RT-PCR and Western blotting methods
quantifyaveragelevelsofgeneexpressioninawholepopulation,one
cannot exclude the possibility that this TR2/S4+ population
contains two groups of cells: one similar to the undifferentiated
hESCs (high Oct4 expression but low/no expression of neural
markers), and the other similar to the NPCs (high levels of neural
markers but no Oct4 expression). Therefore, to confirm that the
expression of Oct4 and Pax6 in the TR2/S4+ cells was not due to
Early Neural Differentiation of hESCs
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and flow cytometry analysis were carried out. The results showed
that Oct4 antibody staining was positive in 97% of hESCs, with
almost 80% cells strongly positive (mean value=156.5). Similarly,
97% of TR2/S4+ cells were also stained positive for Oct4, but the
majorityofcellsexhibitedalowerlevelofOct4(meanvalue=54.49,
Figure 3B, left). No clear Oct4 staining was visible in NPCs (mean
value=2.9). In addition, TR2/S4+ cells showed a clear upregula-
tion of Pax6 signals (mean value=12.4) compared to hESCs (mean
value=3.14), which was not as strong as in the NPCs (mean
value=21.1, Figure 3B, right). Co-staining of Oct4 and Pax6 in situ
confirmed the flow cytometry analysis and clearly demonstrates the
co-existence ofOct4and Pax6 proteins inthe samecell during early
neural differentiation, which are notably expressed in a negatively
correlated manner (Figure 3C).
To explore whether the various levels of Oct4 expression are
regulated at the promoter, we examined the amount of DNA
methylation in the Oct4 promoter region near the transcription start
site. A gradual increase in DNA methylation was observed
throughout the neural differentiation and was negatively correlated
withOct4 mRNAexpression(Figure 3D).InhESCs, verylow levels
of methylation were detected (0.05%), opposed to the heavy
methylation detected in NPCs (84.3%). Interestingly, an interme-
diate DNA methylation level of 48.1% was observed in the TR2/
S4+ cells. Taken together, these results demonstrate that the TR2/
S4+cellsexhibitageneexpressionprofilewhichisdistinctfromboth
undifferentiated hESCs and their fully committed neural progeni-
tors, and co-express both neural progenitor and undifferentiated
pluripotent markers. In addition, Oct4 expression is progressively
downregulated during neural differentiation, which is accompanied
by the upregulation of neural markers.
TR2/S4+ cells generate both neural and non-neural
lineage cell types
Under neural differentiation conditions [16], further culture of
the TR2/S4+ cells lead to the efficient production of NPCs that
express high levels of neural progenitor markers: nestin (97%),
Sox1 (82%) and Pax6 (88%) (Figure 3 and 4) but lack expression of
pluripotent genes (Oct4 and Nanog) or mesoderm and endoderm
markers: GATA6, brachyury and a-fetoprotein (Figure 2) [22].
These neural progenitor cells were able to further differentiate into
neurons and astrocytes as revealed by the positive staining of
MAP2, TUJ1 and GFAP, respectively (Figure 4).
Since Oct4 expression persists in TR2/S4+ cells, albeit at
a lower level, we considered whether these cells were able to
generate non-neural lineages in alternative culture conditions.
Purified TR2/S4+ cells were differentiated via cell aggregate
formation, a method that can initiate spontaneous differentiation
and is widely used to examine the differentiation potential of cells
in vitro [23]. The TR2/S4+ cell aggregates were able to expand in
culture and displayed structures similar to embryoid bodies (EBs)
after 7 days of differentiation in suspension (Figure 5A). These EB-
like aggregates were then dissociated and plated onto adherent
culture dishes for further differentiation. After another 7 days, cells
Figure 1. Sequential loss of Tra-1-81 and SSEA4 expression during neural differentiation of hESCs. (A) & (B) Expression of Tra-1-81,
SSEA4 and SSEA1 during neural differentiation of H1 (A) & H7 (B) hESCs respectively on the indicated days of differentiation. Phase-contrast images
are shown. Scale bar=50 mm. (C) Immunostaining of Tra-1-81 and SSEA4 in H7 hESCs and at day 6 of their neural differentiation. Scale bar=20 mm.
(D) Expression of Tra-1-81, SSEA4 and SSEA1 in hESC-derived neural progenitor cells. Days of the differentiation are indicated.
doi:10.1371/journal.pone.0037129.g001
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analysed for gene expression by qRT-PCR and immunocyto-
chemistry. Real-time RT-PCR showed upregulation of markers of
the three germ layers: neuroectoderm (Pax6, Sox1 and Sox2),
mesoderm (goosecoid (GSC) and Meox1) and endoderm (albumin
(ALB) and GATA6) (Figure 5C), while pluripotent markers, Oct4
and Nanog were downregulated. Immunocytochemistry further
confirmed that the differentiated cells contained progeny from the
three germ layers: AFP, HNF4a and GATA6 for endoderm,
muscle actin for mesoderm, nestin and Pax6 for neuroectoderm
(Figure 5D). These results demonstrate that TR2/S4+ cells are
also capable of differentiating into cells of non-neural lineages.
TR2/S4+ cells cannot be maintained or reverted back to
hESCs in self-renewal culture conditions
TR2/S4+ cells express a high level of FGF5, a marker of post-
implantationprimitiveectodermofmouseembryos[24].Giventhat
mESC-derivedprimitiveectoderm-likecellsarecapableofreverting
back to anESC statewhen re-cultured inmESCself-renewal media
[25],weexaminedwhethertheTR2/S4+cellscanberevertedback
totheiroriginalhESCstate.PurifiedTR2/S4+cellswerere-plated
into matrigel-coated plates and cultured in hESC self-renewal
conditions(Figure6A).Toverifythatanyresultingchangeswerenot
a technical artifact, we purified and cultured TR+/S4+ hESCs as
controls (Figure 6B). Both cell populations showed similar attach-
mentefficiencies(Figure6Aa&6Ba)andcolonieswereclearlyvisible
3 days after plating. By day 7, TR2/S4+ colonies exhibited
structures and morphologies similar to that of hESCs but the
expression of Tra-1-81 and SSEA4 could neither be reactivated nor
maintained (Figure 6Ab). In contrast, control hESCs (TR+/S4+)
expressed high levels of both these markers (Figure 6Bb). This
difference became even more apparent after 14 days of culture
(Figure 6Ac & 6Bc). Consistent with the changes in cell surface
markers, evidentdifferentiation also startedto emergeinthe TR2/
S4+ cells.RT-PCRanalysis confirmedthat expression ofboth Oct4
and Nanog was downregulated in TR2/S4+ cells as the culture
proceeded. Mesoderm and endoderm markers were up-regulated
whiletheexpressionofneuralmarkers,Pax6andSox1,wasreduced,
although the levels remained higher than in hESCs (Figure 6C).
These results are consistent with the data from EB cultures, which
indicate that the cell fate of TR2/S4+ cells are affected by their
culture conditions. In CM cultures, there is limited inhibition of
BMP signaling in cells, at least not to the level induced by the
addition of noggin [16], which may account for the observed non-
neural lineage differentiation. These results further confirm that
TR2/S4+ cells are distinct from undifferentiated hESCs and
cannot be reverted back to their original hESC state by reintroduc-
tion into hESC self-renewal conditions. Furthermore, these cells
cannot be maintained as TR2/S4+ cells under these conditions.
Comparison of TR2/S4+ cells with cells of early embryoid
bodies and definitive endoderm differentiation
Since TR2/S4+ cells are able to generate cells in addition to
the neural lineage, it raises the question of whether these cells are
equivalent to those of early EBs. To answer this question, we
compared our global gene expression data of early neural
differentiation (N1), which resembled the TR2/S4+ cells (over
85% cells are TR2/S4+) [22], with the published microarray data
Figure 2. Gene expression profile in undifferentiated hESCs, TR2/S4+ cells and neural progenitor cells (NPCs). (A) Flow cytometry
analysis of cells co-stained with Tra-1-81 and SSEA4 antibodies in the three stages of neural differentiation and in purified TR2/S4+ cells. (B) qRT-PCR
analysis of marker gene expressions in TR2/S4+ cells, hESCs and NPCs. Standard deviations were calculated from at least three independent
experiments. (C) RT-PCR analysis of LIFR in undifferentiated H1 hESCs, sorted TR2/S4+ cells, unsorted day 9 differentiated cells (9 d diff) and NPCs.
Each lane represents an independent experiment.
doi:10.1371/journal.pone.0037129.g002
Early Neural Differentiation of hESCs
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e37129Figure 3. Oct4 and Pax6 expression in hESCs, TR2/S4+ cells and NPCs. (A) Western blotting image and quantitative histogram showing Oct4
and Nanog protein expression in the three cell types. (B) Flow cytometry analysis of Oct4 and Pax6 expression in the three cell types. Percentages of
total Oct4 positive and high Oct4 expressing cells are indicated. (C) Immunostaining of Oct4 and Pax6 proteins in H7 hESCs, day 6 neural
differentiation (ND-d6) and rosette-forming neuroepithelial cells. Scale bar=20 mm. Arrows indicate cells with high Oct4 and low Pax6 expression;
arrowheads indicate cells with high Pax6 and low Oct4. (D) Bisulphite DNA sequencing of the Oct4 promoter region in hESCs, TR2/S4+ cells and
NPCs. The transcription starting site and the corresponding location of CpG are indicated. Open and closed circles indicate unmethylated and
methylated CpG, respectively.
doi:10.1371/journal.pone.0037129.g003
Figure 4. Neural differentiation of TR2/S4+ cells. TR2/S4+ cells were further differentiated for in N2B27 medium supplemented with noggin
for 1–2 weeks, then without noggin. (A) Phase-contrast images of further culture of TR2/S4+ in neural differentiation media for 3–4 weeks. (B–F)
Immunostaining with the indicated antibodies at different time points: nestin and Sox1 (3–4 weeks), MAP2 and b-tublin III (6 weeks) and GFAP (15
weeks). Scale bar represent 100 mm.
doi:10.1371/journal.pone.0037129.g004
Early Neural Differentiation of hESCs
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gene ontology analysis revealed that the genes significantly
upregulated during EB differentiation have considerable functions
during neural differentiation and development (Table 1) and, as
a result, shared .60% of the functions in biological processes with
those genes upregulated in TR2/S4+ cells. This becomes more
evident when the top 15 functions in the biological process of the
gene-ontology list are compared between the two cell-populations
as over 70% of them appeared in both lists (Table 1). Similarly, the
downregulated genes in both cell populations also shared .60% of
gene ontology functions. Therefore, global gene expression
analysis does provide certain support for the similar phenotype
and differentiation observed between TR2/S4+ cells and the
early EBs (EBs in suspension).
Since cells in the early neural differentiation and early EB
formation share a similar gene expression pattern and phenotype,
we asked whether early mesendoderm differentiation would also
generate this population. To address this question, we differenti-
ated H1 hESCs into definitive endoderm using two different
methods (Activin A with sodium butyrate or LY294002, see
Materials and Methods for details). Both differentiation proce-
dures exhibited a similar phenotype and gene expression pattern,
in which expression of Sox17 and FoxA2 steadily increased over
the 3-day differentiation period, whereas, after an initial upregula-
tion, expression of the mesendoderm markers, brachyury and
Figure 5. Differentiation of TR2/S4+ cells by cell aggregate formation. (A) Images of cell aggregates at day 3 and 7 of differentiation,
respectively. EB-like structures are visible by day 7 (arrows). Scale bar=100 mm. (B) Images of cell aggregates cultured for a further 7 days after
disassociation. Scale bar=100 mm. (C) qRT-PCR analysis of markers in hESCs, TR2/S4+ and their differentiated progeny (TR2/S4+ EB) two weeks after
initiation of differentiation (1 week in suspension and 1 week after dissociation onto adherent dish). (D) Immunostaining with indicated antibodieso n
differentiated progeny of TR2/S4+ cells 1 week after dissociation onto coverslip. Scale bar=50 mm.
doi:10.1371/journal.pone.0037129.g005
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Sox2 expression was continuously downregulated (Figure 7A).
This gene expression pattern is consistent with our previous data
and existing published data on endoderm differentiation [6,7,27],
indicating that the majority of these cells have differentiated to
mesendoderm by day 1–2 of the differentiation and are committed
to endoderm by day 3. However, during the differentiation, both
Tra-1-81 and SSEA4 were continuously expressed in a consider-
able proportion of cells, approximately 90% and 70% after 2 and
3 days of differentiation, respectively (Figure 7B). These results
demonstrated that differentiated mesendoderm and early endo-
derm cells can also express TRA-1-81 and SSEA4, which is in line
with a previous report that found Tra-1-60 and SSEA4 positive
cells in a proportion of Sox17+ cells that could only be
differentiated into endoderm and mesoderm [28]. As a whole,
these results therefore indicate that differentiation towards the
neural lineage may share a similar initial process to differentiation
via EB formation that is distinct from that of high-dose Activin-
induced definitive endoderm differentiation.
Discussion
Differentiation of hESCs to specific cell lineages is a complex
process involving multiple stages. An improved understanding of
this elaborate process will provide further insights into the
molecular control of early developmental processes, which is
fundamental for the realization of targeted drug and cell therapies.
In this study, we focused on the initial stage of hESC neural
differentiation and have identified a transient cell population by
carefully monitoring the expression of hESC stage-specific surface
antigens. These cells no longer express the hESC specific marker
Tra-1-81 but retain expression of SSEA4, another hESC marker.
Although TR2/S4+ cells are able to form EB-like structures
and can differentiate into non-neural lineages (Figure 5), they are
distinct from their original undifferentiated hESCs. They do not
express Tra-1-81, a marker for undifferentiated hESCs [3,17], and
they exhibit an altered gene expression profile when compared to
hESCs. Undifferentiated hESCs express high levels of pluripotent
genes (Oct4, Nanog and LRH-1) but do not express neural lineage
markers (Pax6, nestin and Sox1), whereas TR2/S4+ cells express
Figure 6. TR2/S4+ cells cultured in MEF-CM supplemented with bFGF. (A) & (B) TR2/S4+ cells (A) and TR+/S4+ hESCs (B) were isolated and
cultured in hESC self-renewal conditions for 1 (a), 7 (b) and 14 (c) days. Phase-contrast images and flow cytometry analysis of Tra-1-81 and SSEA4
expression are shown in the left and right, respectively. Scale bar=100 mm. (C) qRT-PCR analysis of marker genes in TR2/S4+ cells after 0 (TR2/S4+),
7 (R-CM7d) and 14 (R-CM14d) days of culture in MEF-CM hESC culture conditions compared with hESCs.
doi:10.1371/journal.pone.0037129.g006
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levels. Furthermore, their response to extrinsic signals also differs
from hESC. When reintroduced into hESC self-renewal culture
conditions, they were unable to maintain the low-level co-
expression of both Oct4 and Pax6 with Tra-1-81(2)/SSEA4(+)
identity, nor were they able to revert back to a Tra-1-81(+)/
SSEA4(+) hESC state expressing high levels of Oct4. Instead, they
differentiated into mixed neural and non-neural lineages. On the
other hand, these cells are also different from committed NPCs.
Fully differentiated neural progenitors do not express pluripotent
genes, but do express high levels of neural markers, whereas the
TR2/S4+ cells co-express both pluripotent and neural markers.
Therefore, these cells represent an intermediate stage between
pluripotent hESCs and differentiated NPCs.
The TR2/S4+ cells share several similarities with the mouse
primitive NSCs that were identified in studies in the initial stage of
neural ectoderm differentiation/formation in mESCs and embryos
[4,29]. Both cell types were identified in the early stage of neural
development and express pluripotent and neural genes in addition
to FGF5. They are capable of producing not only neural
progenitors but also non-neural lineage cells, depending on their
environmental cues. However, TR2/S4+ cells do not share all the
features of mouse primitive NSCs, the main difference being their
response to LIF stimulation. LIF has been reported to stimulate an
increase in proliferation in mouse primitive NSCs [4], whereas we
found that TR2/S4+ cells were unresponsive to LIF and express
very low levels of the LIF receptor (Figure 2C). This discrepancy
may reflect differences in the signaling pathways that regulate and
maintain self-renewal and differentiation of human and mouse
ESCs. Mouse ESCs require LIF and BMP to maintain their self-
renewal [30] and FGF signaling promotes their neural differen-
tiation [31]. However, human ESCs require bFGF and Activin for
their self-renewal [3,32], with the inhibition of BMP and Activin
leading to their neural differentiation [16,20]. Interestingly, the
TR2/S4+ cells also share similar changes in gene expression
pattern with the cells of early EBs. This finding may further
Table 1. Top 15 functions of the genes up- or down- regulated in TR2/S4+ and early EB cells.
TR2/S4+ upregulated genes * Benjamini EB upregulated genes Benjamini
1 multicellular organismal process (2) 1.40E-22 1 nervous system development 1.60E-14
2 system development (3) 6.30E-12 2 multicellular organismal process 5.40E-13
3 multicellular organismal development (5) 7.90E-12 3 system development 2.30E-12
4 anatomical structure development (4) 1.10E-11 4 anatomical structure development 6.30E-12
5 system process (20) 2.20E-11 5 multicellular organismal development 7.00E-11
6 developmental process (6) 2.70E-10 6 developmental process 1.80E-10
7 cell surface receptor linked signal transduction 4.90E-09 7 central nervous system development 2.30E-08
8 nervous system development (1) 4.70E-08 8 cell differentiation 5.50E-07
9 neurological system process (23) 1.10E-07 9 neurogenesis 5.60E-07
10 G-protein coupled receptor protein signaling pathway 1.80E-07 10 axonogenesis 6.70E-07
11 organ development 2.20E-07 11 cellular developmental process 7.40E-07
12 cellular developmental process (11) 5.40E-06 12 cell morphogenesis involved in neuron differentiation 2.50E-06
13 cell differentiation (8) 5.10E-06 13 generation of neurons 2.50E-06
14 cognition 5.50E-06 14 cell projection morphogenesis 3.30E-06
15 central nervous system development (7) 5.30E-06 15 neuron projection morphogenesis 4.20E-06
TR2/S4+ downregulated genes* Benjamini EB downregulated genes Benjamini
1 multicellular organismal development 6.00E-15 1 immune response 5.40E-09
2 developmental process 2.70E-14 2 response to wounding 9.20E-08
3 multicellular organismal process (9) 2.40E-13 3 response to external stimulus 2.70E-07
4 system development (18) 8.20E-12 4 defense response 3.40E-07
5 anatomical structure development (25) 1.10E-10 5 immune system process 4.80E-07
6 organ development (20) 2.50E-10 6 positive regulation of biological process 2.70E-06
7 response to external stimulus (3) 2.10E-09 7 inflammatory response 4.80E-06
8 positive regulation of biological process (6) 5.10E-09 8 response to stimulus 7.30E-06
9 organ morphogenesis 7.50E-09 9 multicellular organismal process 1.50E-05
10 cell-cell signaling 1.50E-08 10 positive regulation of cellular process 5.70E-05
11 regulation of cell proliferation (11) 1.50E-08 11 regulation of cell proliferation 5.50E-05
12 cell communication 5.50E-08 12 positive regulation of immune system process 6.10E-04
13 positive regulation of cellular process 5.40E-08 13 response to stress 8.40E-04
14 immune system process (1) 1.40E-07 14 regulation of response to stimulus 7.80E-04
15 anatomical structure morphogenesis 3.90E-07 15 regulation of immune system process 1.20E-03
*Number in the bracket represents the position of gene ontology ranking in EB cells.
doi:10.1371/journal.pone.0037129.t001
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ectoderm as EB differentiation, to a certain extent, resembles the in
vivo development of the embryo in which primitive ectoderm is one
of the first lineages to form [25]. It is also noteworthy that similar
TR2/S4+ cells were not detected during endoderm differentia-
tion. Although the underlying implication of this observation
remains to be elucidated, this suggests that the differentiation
process towards endoderm and neural lineages are distinct from
each other and may additionally affect the expression of cell
surface antigens. This finding is also supported by a recent report
that showed changes in glycosphoingolipid composition during
endoderm differentiation that were entirely different from those in
neural differentiation and EB formation [33].
Our data also shows that prior to the establishment of a fully
committed neural lineage (demonstrated by high expression of
neural genes and an absence of pluripotent markers), changes in
culture conditions can alter the differentiation outcome. For
example, if the culture conditions are maintained in favor of
neural differentiation, expression of neural genes, including Sox2,
are further increased, whilst expression of Oct4 and Nanog are
reduced, and cells are committed to neural progenitors. Other-
wise, under different culture conditions, cells can be differentiated
to a non-neural fate.
One interesting observation is the dynamic changes in
expression of the pluripotent genes Oct4 and Sox2. Both have
been intensively studied as central regulators for the maintenance
of ESC pluripotency [8,13,34,35], and as key factors required to
reprogram somatic cells to the embryonic state [36,37]. However,
it is unclear how or if these pluripotent factors play a role in the
transition from a pluripotent cell to a lineage–specific cell type. In
this study we have demonstrated that the downregulation of Oct4
during neural differentiation of hESCs is progressive and is
accompanied by the gradual upregulation of neural markers
(Figure 3). The relationship between Oct4 and neural genes
appear to be negatively correlated, and it appears that the neural
lineage cannot be fully established prior to complete repression of
Oct4. By contrast, Sox2 is consistently expressed during this
process and is upregulated in the neural progenitors. These data
are in line with the recent finding [38] that Oct4 and Sox2 are
differentially expressed during neural and mesendoderm differen-
tiation and suggests that pluripotent genes may play a role during
early differentiation of the embryo proper. Oct4 has been shown
to function in mouse trophectoderm differentiation by interacting
with the trophectoderm transcription factor Cdx2, the resulting
complex of which enhances Cdx2 expression and represses Oct4
expression [39]. Similarly, in mesoderm and endoderm differen-
tiation, Oct4 interacts with the Sox17 transcription factor to
repress Sox2 expression and enhance Sox17 expression [40].
However, in these non-neural lineages, Oct4 expression was
maintained, and even slightly upregulated during the initial stages
of the differentiation, which is not the case during neural
differentiation. Therefore, Oct4 may not be directly involved in
neural differentiation, but may rather function as a gate-keeping
gene to govern pluripotency [41]. By contrast, Sox2 has been
found to play a critical role in the maintenance of neural
progenitor stem cells [42]. In keeping with this, we showed that
Sox2 expression remains high throughout neural differentiation,
thus suggesting that Sox2 may be a key player in the initiation of
neural differentiation. However, how Sox2 regulates the neural
initiation and, in particular, its relationship with Oct4 during this
process remains to be elucidated. As such, these TR2/S4+ cells
will be both a valuable and useful cell type for such an
investigation.
Figure 7. Differentiation of H1 hESCs to definitive endoderm. H1 hESCs were treated with high levels of Activin A and LY294002 for 3 days as
detailed in Materials and Methods. The cells were stained with Tra-1-81 and SSEA4 antibodies and analysed for their gene expression by q-RT-PCR at
the indicated time points during the differentiation. (A) Expression of marker genes were analysed by qRT-PCR at the indicated time points during the
differentiation. (B) Phase-contrast images and histogram of flow cytometry analysis on Tra-1-81 and SSEA4 antibody staining at the indicated time
points. Scale bar=100 mm.
doi:10.1371/journal.pone.0037129.g007
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Culture and differentiation of hESCs
Human embryonic stem cell lines H1 and H7 (WiCell) were
routinely cultured on matrigel-coated plates using mouse embry-
onic fibroblast-conditioned medium (MEF-CM) supplemented
with 8 ng/ml bFGF (PeproTech) and propagated mechanically in
1:3 ratio after the treatment with collagenase IV [43]. Neural
differentiation was carried out in N2B27 medium supplemented
with 100 ng/ml noggin (R&D systems) alone [16] or with 500 ng/
ml noggin and 10 mM SB431542 [20,21] in poly-L-lysine/laminin
or matrigel coated plates. After formation of neural progenitor
cells, noggin was replaced by bFGF (20 ng/ml) and NPCs were
maintained in this condition and propagated with TrypLE
(Invitrogen). Neurons and glia were differentiated by withdrawal
of bFGF. Differentiation via cell aggregate formation was carried
out as described previously [44], with 1610
4 cells/aggregate in 96-
well plate. Aggregates were transferred into a 24 well plate and
cultured in suspension for a week. They were then mechanically
dissociated and cultured in gelatin-coated plates/coverslips. De-
finitive endoderm differentiation was performed using two
different protocols: 1) hESCs were treated with 100 ng/ml Activin
A and 0.5–1 mM sodium butyrate as described previously [7]; 2)
the hESCs were treated with 100 ng/ml Activin A (PeperoTech)
and 20 mM LY294002 (Sigma) in RPMI1641-B27 medium for 1
day followed by 100 ng/ml Activin A and 10 mM LY294002 for
another 2 days supplemented with 0.1% insulin-transferrin-
selenium (ITS, Sigma).
Immunocytochemistry and Western blotting
Cells were fixed at room temperature with 4% paraformalde-
hyde for 10 minutes. Non-specific proteins were blocked by
incubation in PBS containing 10% goat serum (Sigma) and 0.1%
Triton-X for one hour. The cells were then treated with primary
antibodies overnight at 4uC. Following PBS washes, cells were
incubated with fluorescence-conjugated secondary antibody for
30 minutes, and finally mounted to cover-slip with Mowiol. For
cell surface antigens, cells were stained live (without fixation),
incubated with primary antibody for 1 h at 4uC, washed with PBS
and then incubated with the appropriate secondary antibody for
30 minutes at 4uC. The staining was visualized and captured with
a Nikon Eclipse TC2000-U microscope or Leica TCS SP5.
For Western blotting, cells were lysed in pre-heated 1% sodium
dodecyl sulphate (SDS) and homogenized by passing through
a needle. The supernatant was collected after centrifugation and
assayed for protein concentration using bicinchoninic acid protein
assay kit (Pierce). 50 mg lysate from each sample were separated in
10% SDS-PAGE gel and transferred onto a polyvinylidene
fluoride (PVDF) membrane. Membranes were blocked for 1 h in
Tris-buffered saline (TBS) containing 0.1% Tween (TBST) and
5% milk prior to incubation with the appropriate primary
antibody overnight at 4uC. Membranes were washed twice with
TBST and incubated with HRP-conjugated secondary antibodies
at a dilution of 1:2000 for 1 h at room temperature and were
visualized by enhanced chemiluminescence (Pierce). All antibodies
are listed in Table S1.
Flow cytometry analysis and cell sorting
Cells were detached into single cells by trypsin/EDTA,
incubated with antibody directly (for surface antigens) or following
fixation with 4% paraformaldehyde (for 15 min) and permeation
with 100% ethanol (2 min) (for nuclear proteins). Cells were
analysed using a BD FACSCalibur and CELLQUEST software.
Fluorescence-activated cell sorting (FACS) was carried out with
BD FACSAria II after staining live cells with antibodies against
cell surface antigens. Magnetic-activated cell sorting was per-
formed with Dynal magnetic beads (Invitrogen) following the
manufacturer’s instructions. Briefly, 25 ml( 1 610
7) Dynabeads
were pre-coated with 1 mg primary antibody by incubation at 4uC
for 30 minutes in 1 ml buffer 1. Pre-coated beads were then
incubated with cells (0.5 ml) at 4uC for 30 minutes with gentle
tilting and rotation. 2 ml buffer 1 was added into the tube to limit
trapping of unbound cells before placing the tube onto the magnet
for 2 minutes. For negative selection, the supernatant, containing
the unbound cells, was transferred to a fresh tube for further
experiments. For positive isolation, the bead-bound cells were
gently washed with buffer 1 and collected in appropriate solution/
medium for further experiments.
Gene expression analysis by quantitative RT-PCR (qRT-
PCR)
Total RNA was extracted using TRI reagent solution (Sigma)
following the manufacturer’s instructions. Remaining traces of
DNA were removed by DNase I treatment (Invitrogen). Reverse
transcription and qPCR were performed as described previously
[45]. RNA without reverse transcription was used as a negative
control. The relative gene expression levels were calculated by
calibrating their Ct values with those of housekeeping genes,
HPRT and GAPDH, and then normalized to undifferentiated
hESCs. The standard deviation was calculated from at least four
qPCRs from three independent experiments. Primer sequences
are listed in Table S2.
Global gene expression analysis
RNA-sequencing data was generated as previously reported
[22]. Microarray data was obtained from publically available
database [26]. Significantly upregulated or downregulated genes
($5-folds) were selected and analysed using DAVID bioinfor-
matics resources [46].
Supporting Information
Figure S1 Expression of Tra-1-81 and SSEA4 during
neural differentiation of hESCs with dual SMAD in-
hibition protocol. Neural differentiation with dual SMAD
inhibition protocol also exhibits the sequential loss of Tra-1-81 and
SSEA4. Flow cytometry histogram showing Tra-1-81 and SSEA4
staining in hESCs and at day 9 of the neural differentiation.
(TIF)
Table S1 Antibodies used for immunocytochemistry,
FACS and Western blotting.
(DOCX)
Table S2 Primer sequences for RT-PCR.
(DOCX)
Acknowledgments
We thank Dr. Meng Li, Professor Malcolm Parker and Dr. Veronique
Azuara for critical reading of the manuscript and helpful discussion. We
thank Dr. Wei Dai for help in using DAVID bioinformatics software.
Author Contributions
Conceived and designed the experiments: PN TSR FRL JSLY AR WC.
Performed the experiments: PN TSR FRL JSLY MS AR XJ. Analyzed the
data: PN TSR FRL JSLY MS WC. Contributed reagents/materials/
analysis tools: PN TSR FRL JSLY MS AR XJ. Wrote the paper: PN FRL
JSLY WC.
Early Neural Differentiation of hESCs
PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e37129References
1. Conti L, Cattaneo E (2010) Neural stem cell systems: physiological players or in
vitro entities? Nat Rev Neurosci 11: 176–187.
2. Gotz M, Huttner WB (2005) The cell biology of neurogenesis. Nat Rev Mol Cell
Biol 6: 777–788.
3. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, et al.
(1998) Embryonic stem cell lines derived from human blastocysts. Science 282:
1145–1147.
4. Tropepe V, Hitoshi S, Sirard C, Mak TW, Rossant J, et al. (2001) Direct neural
fate specification from embryonic stem cells: a primitive mammalian neural stem
cell stage acquired through a default mechanism. Neuron 30: 65–78.
5. Okada Y, Matsumoto A, Shimazaki T, Enoki R, Koizumi A, et al. (2008)
Spatiotemporal recapitulation of central nervous system development by murine
embryonic stem cell-derived neural stem/progenitor cells. Stem Cells 26:
3086–3098.
6. Cai J, Zhao Y, Liu Y, Ye F, Song Z, et al. (2007) Directed differentiation of
human embryonic stem cells into functional hepatic cells. Hepatology 45:
1229–1239.
7. Hay DC, Zhao D, Fletcher J, Hewitt ZA, McLean D, et al. (2008) Efficient
differentiation of hepatocytes from human embryonic stem cells exhibiting
markers recapitulating liver development in vivo. Stem Cells 26: 894–902.
8. Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct-3/4
defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet
24: 372–376.
9. Chambers I, Tomlinson SR (2009) The transcriptional foundation of
pluripotency. Development 136: 2311–2322.
10. Yamanaka S, Blau HM (2010) Nuclear reprogramming to a pluripotent state by
three approaches. Nature 465: 704–712.
11. Yeom YI, Fuhrmann G, Ovitt CE, Brehm A, Ohbo K, et al. (1996) Germline
regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells.
Development 122: 881–894.
12. Fang H, Yang Y, Li C, Fu S, Yang Z, et al. (2010) Transcriptome analysis of
early organogenesis in human embryos. Dev Cell 19: 174–184.
13. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, et al. (1998)
Formation of pluripotent stem cells in the mammalian embryo depends on the
POU transcription factor Oct4. Cell 95: 379–391.
14. Hay DC, Sutherland L, Clark J, Burdon T (2004) Oct-4 knockdown induces
similar patterns of endoderm and trophoblast differentiation markers in human
and mouse embryonic stem cells. Stem Cells 22: 225–235.
15. Zafarana G, Avery SR, Avery K, Moore HD, Andrews PW (2009) Specific
knockdown of OCT4 in human embryonic stem cells by inducible short hairpin
RNA interference. Stem Cells 27: 776–782.
16. Gerrard L, Rodgers L, Cui W (2005) Differentiation of human embryonic stem
cells to neural lineages in adherent culture by blocking bone morphogenetic
protein signaling. Stem Cells 23: 1234–1241.
17. Henderson JK, Draper JS, Baillie HS, Fishel S, Thomson JA, et al. (2002)
Preimplantation human embryos and embryonic stem cells show comparable
expression of stage-specific embryonic antigens. Stem Cells 20: 329–337.
18. Enver T, Pera M, Peterson C, Andrews PW (2009) Stem cell states, fates, and
the rules of attraction. Cell Stem Cell 4: 387–397.
19. Pruszak J, Sonntag KC, Aung MH, Sanchez-Pernaute R, Isacson O (2007)
Markers and methods for cell sorting of human embryonic stem cell-derived
neural cell populations. Stem Cells 25: 2257–2268.
20. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, et al.
(2009) Highly efficient neural conversion of human ES and iPS cells by dual
inhibition of SMAD signaling. Nat Biotechnol 27: 275–280.
21. Shi Y, Kirwan P, Smith J, Robinson HP, Livesey FJ (2012) Human cerebral
cortex development from pluripotent stem cells to functional excitatory synapses.
Nat Neurosci. nn.3041 [pii];10.1038/nn.3041 [doi].
22. Wu JQ, Habegger L, Noisa P, Szekely A, Qiu C, et al. (2010) Dynamic
transcriptomes during neural differentiation of human embryonic stem cells
revealed by short, long, and paired-end sequencing. Proc Natl Acad Sci U S A
107: 5254–5259.
23. Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, et al. (2000)
Differentiation of human embryonic stem cells into embryoid bodies
compromising the three embryonic germ layers. Mol Med 6: 88–95.
24. Haub O, Goldfarb M (1991) Expression of the fibroblast growth factor-5 gene in
the mouse embryo. Development 112: 397–406.
25. Rathjen J, Lake JA, Bettess MD, Washington JM, Chapman G, et al. (1999)
Formation of a primitive ectoderm like cell population, EPL cells, from ES cells
in response to biologically derived factors. J Cell Sci 112 (Pt 5): 601–612.
26. Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, et al. (2011) Reference
Maps of human ES and iPS cell variation enable high-throughput character-
ization of pluripotent cell lines. Cell 144: 439–452.
27. D’Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, et al. (2005)
Efficient differentiation of human embryonic stem cells to definitive endoderm.
Nat Biotechnol 23: 1534–1541.
28. Wang P, Rodriguez RT, Wang J, Ghodasara A, Kim SK (2011) Targeting
SOX17 in human embryonic stem cells creates unique strategies for isolating
and analyzing developing endoderm. Cell Stem Cell 8: 335–346.
29. Hitoshi S, Seaberg RM, Koscik C, Alexson T, Kusunoki S, et al. (2004)
Primitive neural stem cells from the mammalian epiblast differentiate to
definitive neural stem cells under the control of Notch signaling. Genes Dev 18:
1806–1811.
30. Ying QL, Nichols J, Chambers I, Smith A (2003) BMP induction of Id proteins
suppresses differentiation and sustains embryonic stem cell self-renewal in
collaboration with STAT3. Cell 115: 281–292.
31. Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray J, Meloche S, et al.
(2007) FGF stimulation of the Erk1/2 signalling cascade triggers transition of
pluripotent embryonic stem cells from self-renewal to lineage commitment.
Development 134: 2895–2902.
32. Vallier L, Alexander M, Pedersen RA (2005) Activin/Nodal and FGF pathways
cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci
118: 4495–4509.
33. Liang YJ, Yang BC, Chen JM, Lin YH, Huang CL, et al. (2011) Changes in
glycosphingolipid composition during differentiation of human embryonic stem
cells to ectodermal or endodermal lineages. Stem Cells 29: 1995–2004.
34. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, et al. (2005) Core
transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:
947–956.
35. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, et al. (2007)
Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse
embryonic stem cells. Nat Cell Biol 9: 625–635.
36. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from
mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:
663–676.
37. Kim JB, Sebastiano V, Wu G, rauzo-Bravo MJ, Sasse P, et al. (2009) Oct4-
induced pluripotency in adult neural stem cells. Cell 136: 411–419.
38. Thomson M, Liu SJ, Zou LN, Smith Z, Meissner A, et al. (2011) Pluripotency
factors in embryonic stem cells regulate differentiation into germ layers. Cell
145: 875–889.
39. Niwa H, Toyooka Y, Shimosato D, Strumpf D, Takahashi K, et al. (2005)
Interaction between Oct3/4 and Cdx2 determines trophectoderm differentia-
tion. Cell 123: 917–929.
40. Stefanovic S, Abboud N, Desilets S, Nury D, Cowan C, et al. (2009) Interplay of
Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to
specifying a cardiac fate. J Cell Biol 186: 665–673.
41. Pesce M, Scholer HR (2001) Oct-4: gatekeeper in the beginnings of mammalian
development. Stem Cells 19: 271–278.
42. Graham V, Khudyakov J, Ellis P, Pevny L (2003) SOX2 functions to maintain
neural progenitor identity. Neuron 39: 749–765.
43. Gerrard L, Zhao D, Clark AJ, Cui W (2005) Stably transfected human
embryonic stem cell clones express OCT4-specific green fluorescent protein and
maintain self-renewal and pluripotency. Stem Cells 23: 124–133.
44. Burridge PW, Anderson D, Priddle H, Barbadillo M, Chamberlain S, et al.
(2007) Improved human embryonic stem cell embryoid body homogeneity and
cardiomyocyte differentiation from a novel V-96 plate aggregation system
highlights interline variability. Stem Cells 25: 929–938.
45. Noisa P, Urrutikoetxea-Uriguen A, Li M, Cui W (2010) Generation of human
embryonic stem cell reporter lines expressing GFP specifically in neural
progenitors. Stem Cell Rev 6: 438–449.
46. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative
analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:
44–57.
Early Neural Differentiation of hESCs
PLoS ONE | www.plosone.org 11 May 2012 | Volume 7 | Issue 5 | e37129